Monoclonal Antibody Treatments Protective Against RSV Infection Among Vulnerable Infants, Meta-Analysis Indicates

March 16, 2023

Infectious Disease Advisor (3/15, Nye) reports, “Results of a systematic review and network meta-analysis published in JAMA Network Open suggest that treatment with [monoclonal antibody treatments] motavizumab, nirsevimab, or palivizumab is significantly...